Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 6, 2000, Pages 551-556

  Tan, Wen ^a   Song, Nan ^a   Wang, Gui Qi ^a   Liu, Qing ^b   Tang, Huai Jing ^a   Kadlubar, Fred F ^c   Lin, Dong Xin ^a  

^a CANCER HOSPITAL   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; GLUTATHIONE TRANSFERASE;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CHINA; ESOPHAGUS CANCER; FEMALE; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; CYTOCHROME P-450 CYP2E1; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; NITROSAMINES; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 0034046238     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Li, J. Y., Liu, B. Q., Li, G. Y., Chen, Z. J., and Sun, X. I. Atlas of cancer mortality in the People's Republic of China. An aid for cancer control and research. Int. J. Epidemiol., 10: 127-133, 1981.
2. Qiu, S. L., and Yang, G. Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China. Cancer (Phila.), 62: 551-557, 1988.
3. Crespi, M., Munoz, N., Grassi, A., Shen, Q., Wang, G-Q., and Lin, J. J. Precursor lesions of oesophageal cancer in a low-risk population in China: comparison with high-risk population. Int. J. Cancer, 34: 599-602, 1984.
4. Wang, L-D., Hong, J., Qiu, S. L., Gao, H., and Yang, C. S. Accumulation of p53 protein in human esophageal precancer lesions: a possible early biomarker for carcinogenesis. Cancer Res., 53: 1783-1787, 1993.
5. Lu, S. H., Yang, W. X., Guo, L. P., Li, F. M., Wang, G. J., Zhang, J. S., and Li, P. Z. Determination of N-Nitrosamines in Gastric Juice and Urine and a Comparison of Endogenous Formation of N-Nitrosoproline and Its Inhibition in Subjects from High-and Low-Risk Areas for Esophageal Cancer. IARC Sci. Publ., 84: 538-543, 1987.
6. Lu, S. H., Chui, S. X., Yang, W. X., Hu, X. N., Guo, L. P., and Li, F. M. Relevance of N-nitrosamines to oesophageal cancer in China. IARC Sci. Publ., 105: 11-17, 1991.
7. Cheng, K. K., Day, N. E., Duffy, S. W., Lam, T. H., Fok, M., and Wong, J. Pickled vegetables in the aetiology of esophageal cancer in Hong Kong Chinese. Lancet, 339: 1314-1318, 1992.
8. Wu, Y., Chen, J., Oshima, H., Pignatelli, B., Boreham, J., Li, J., Campbell, T. C. Peto, R., Bartsch, H. Geographic association between urinary excretion of N-nitroso compounds and oesophageal cancer mortality in China. Int. J. Cancer, 54: 713-719, 1993.
9. Nebert, D. W., McKinnon, R. A., and Puga, A. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer. DNA Cell Biol., 15: 273-280, 1996.
10. Gonzalez, F. J. The role of carcinogen-metabolizing enzyme polymorphisms in cancer susceptibility. Reprod. Toxicol., 11: 397-412, 1997.
11. Guengerich, F. P., Kim, D.-H., and Iwasaki, M. Role of human cytochrome P-450IIE1 in the oxidation of many low molecular weight cancer suspects. Chem. Res. Toxicol., 4: 168-179, 1991.
12. Yang C. S., Yoo, J. S. H., Ishizaki, H., and Hong, J. Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab. Rev., 22: 147-159, 1990.
13. Albano, E., Tomasi, A., Person, J. O., Terelius, Y., Goria-Gatti, L., Ingelman-Sundberg, M., and Dianzani, M. U. Role of ethanol-inducible cytochrome P-450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols. Biochem Pharmacol., 41: 1895-1902, 1991.
14. Ingelman-Sundberg, M., Johansson, I., Yin, H., Terelius, Y., Eliasson, E., Clot, P., and Albano, E. Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol, 10: 447-452, 1993.
15. Lechevrel, M., Casson, A. G., Wolf, C. R., Hardie, L. J., Flinterman, M. B., Motesano, R., and Wild, C. P. Characterization of cytochrome P450 expression in human oesophageal mucosa. Carcinogenesis (Lond.), 20: 243-248, 1999.
16. Wheeler, C. W., Wrighton, S. A., and Guenthner, T. M. Detection of human lung cytochrome P450 that are immunochemically related to cytochrome P450IIE1 and cytochrome P450IIIA. Biochem. Pharmacol., 44: 183-187, 1992.
17. Nakajima, T., Wang, R-S., Nimura, Y., Pin, Y-M., He, M., Vainio, H., Murayama, N., Aoyama, T., and Iida, F. Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis (Lond.), 17: 1477-1481, 1996.
18. Guengerich, F. P., and Turvy, C. G. Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther., 256: 1189-1194, 1991.
19. Lucas, D., Berthou, F., Dreano, Y., Lozac'h, P., Volant, A., and Menez, J. F. Comparison of levels of cytochromes P-450, CYP1A2, CYP2E1, and their related monooxygenase activities in human surgical liver samples. Alcohol. Clin. Exp. Res., 17: 900-905, 1993.
20. Lucas, D., Menez, C., Girre, C., Berthou, F., Bodenez, P., Joannet, I., Hispard, E., Bardou, L-G., and Menez, J-F. Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in health and alcoholic Caucasian subjects. Pharmacogenetics, 5: 298-304, 1995.
21. Hayashi, S., Watanabe, J., and Kawajiri, K. Genetic polymorphism in the 5′-flanking region changes the transcriptional regulation of the human cytochrome P450IIE1 gene. J. Biochem., 110: 559-565, 1991.
22. Uematsu, F., Kikuchi, H., Motomiya, M., Abe, T., Sagami, I., Omachi, T., Wakui, A., Kanamaru, R., and Watanabe, M. Association between restriction fragment length polymorphism of human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn. J. Cancer Res., 82: 254-256, 1991.
23. Hu, Y., Oscarson, M., Johansson, I., Yue, Q-Y., Dahl, M-L., Tabone, M., Arinco, S., Albano, E., and Ingelman-Sundberg, M. Genetic polymorphism of human CYP2E1: characterization of two variant alleles. Mol. Pharmacol., 51: 370-376, 1997.
24. Carriere, V., Berthou, F., Baird, S., Belloe, C., Beaune, P., and de Waziers, I. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics, 6: 203-211, 1996.
25. Kim, R. B., O'Shea, D., and Wilkinson, G. R. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms. Clin. Pharmacol. Ther., 57: 645-655, 1995.
26. Kim, R. B., Yamazaki, H., Chiba., K., O'Shea, D., Mimura, F., Guengerich, F. P., Ishizaki, T., Shimada, T., and Wilkinson, G. R. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J. Pharmacol. Exp. Ther., 279: 4-11, 1996.
27. Le Marchand, L., Wilkinson, G. R., and Wilkens, L. R. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol. Biomark. Prev., 8: 495-500, 1999.
28. Watanabe, J., Hayashi, S., and Kawajiri, K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J. Biochem., 116: 321-326, 1994.
29. Seidegaard, J., Pero, R. W., Miller, D. J., and Beattie, E. J. A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis (Lond.), 7: 751-753, 1986.
30. Pemble, S., Schroeder, K. R., Spenser, S. R., Meyer, D. J., Hallier, E., Bolt, H. M., Ketterer, B., and Taylor, J. B. Human glutathione S-transferase θ (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem. J., 300: 271-276, 1994.
31. Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L., and Lucier, G. W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst., 85: 1159-1164, 1993.
32. Lin, D-X., Tang, Y-M., Peng, Q., Lu, S-X., Ambrosone, B., and Kadlubar, F. F. Susceptibility to esophageal cancer and genetic polymorphisms in glutathione S-transferases T1, P1, and M1 and cytochrome P450 2E1. Cancer Epidemiol. Biomark. Prev., 7: 1013-1018, 1998.
33. Nelson, H. H., Wiencke, J. K., Christiani, D. C., Cheng, T. J., Zuo, Z-F., Schwartz, B. S., Lee, B-K., Spitz, M. R., Wang, M., Xu, X-P., and Kelsey, K. T. Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase θ. Carcinogenesis (Lond.), 16: 1243-1245, 1995.
34. Rebbeck, T. R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomark. Prev., 6: 733-743, 1997.
35. Strange, R. C., Lear, J. T., and Fryer, A. A. Glutathione S-transferase polymorphisms: influence on susceptibility to cancer. Chem. Biol. Interact., 111-112: 351-364, 1998.
36. Houlston, R. S. Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol. Biomark. Prev., 8: 675-682, 1999.
37. Baily, L. R, Roodi, N., Verrier, C. S., Yee, C. J., Dupont, W. D., and Parl, F. F. Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res., 58: 65-70, 1998.
38. Chen, C., Madeleine, M. M., Lubinski, C., Weiss, N. S., Tichman, E. W., and Daling, J. R. Glutathione S-transferase M1 genotypes and the risk of anal cancer: a population-based case-control study. Cancer Epidemiol. Biomark. Prev., 5: 985-991, 1996.
39. Chen, H., Sandler, D. P., Taylor, J. A., Shore, D. L., Liu, E., Bloomfield, C. D., and Bell, D. A. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase θ 1 (GSTT1) gene defect. Lancet, 347: 295-297, 1996.
40. Peters, W. H. M., Roelofs, H. M. J., Hectors, M. P. C., Nagengast, F. M., and Jansen, J. B. M. J. Glutathione and glutathione S-transferases in Barrett's epithelium. Br. J. Cancer, 67: 1413-1417, 1993.
41. Zimniak, P., Nanduri, B., Pikula, S., Bandorowicz-Pikula, J., Singhal, S., Srivastava, S. K., Awasthi, S., and Awasthi, J. C. Naturally occurring human glutathione S-transferase GSTP1-I isoforms with isoleucine and valine at position 104 differ in enzymatic properties. Eur. J. Biochem., 224: 893-899, 1994.
42. Hu, X., Xia, H., Srivastava, S. K., Herzog, C., Awasthi, Y. C., Ji, X., Zimniak, P., and Singh, S. V. Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for epoxides of polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun., 238: 397-402, 1997.
43. Sundberg, K., Johansson, A-S., Stenberg, G., Widersten, M., Seidel, A., Mannervik, B., and Jemstrom, B. Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis (Lond.), 19: 433-436, 1998.
44. Harris, M. J., Coggan, M., Langton, L., Wilson, S. R., and Board, P. G. Polymorphism of the Pi class glutathione S-transferases in normal population and cancer patients. Pharmacogenetics, 8: 27-31, 1998.
45. van Lieshout, E. M. M., Roelofs, H. M. J., Dekker, S., Mulder, C. J. J., Wobbes, T., Jansen, J. B. M. J., and Peters, W. H. M. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res., 59: 586-589, 1999.
46. El-Zein, R. A., Zwischenberger, J. B., Abdel-Rahman, S. Z., Sankar, A. B., and Au, W. W. Polymorphism of metabolizing genes and lung cancer histology: prevalence of CYP2E1 in adenocarcinoma. Cancer Lett., 112: 71-78, 1997.
47. Oyama, T., Kawamoto, T., Mizoue, T., Sugio, K., Kodama, Y., Mitsudomi, T., and Yasumoto, K. Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer: in relation to p53 gene mutation. Anticancer Res., 17: 583-587, 1997.
48. Persson, I., Johansson, I., Bergling, H., Dahl, M. L., Seidegard, J., Rylander, R., Rannug, A., Hogberg, J., and Ingelman-Sundberg, M. Genetic polymorphism of cytochrome P4502E1 in a Swedish population: relationship to incidence of lung cancer. FEBS Lett., 319: 207-211, 1993.
49. Shields, P. G., Ambrosone, C. B., Graham, S., Bowman, E. D., Harrington, A. M., Gillenwater, K. A., Marshall, J. R., Vena, J. E., Laughlin R., Nemoto, T., and Freudenheim, J. L. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer. Mol. Carcinog., 17: 144-150, 1996.
50. Ladero, J. M., Agundez, J. A., Rodriguez-Lescure, A., Diaz-Rubio, M., and Benitez, J. RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma. Gut, 39: 330-333, 1996.
51. Yu, M-W., Gladek-Yarborough, A., Chiamprasert, S., Santella, R. M., Liaw, Y-F., and Chen, C-J. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology, 109: 1266-1273, 1995.
52. Morita, S., Yano, M., Shiozaki, H., Tsujinaka, T., Ebisui, C., Morimoto, T., Kishibuti, M., Fujita, J., Ogawa, A., Taniguchi, M., Inoue, M., Tamura, S., Yamazaki, K., Kikkawa, N., Mizunoya, S., and Monden, M. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous cell carcinoma of the esophagus. Int. J. Cancer, 71: 192-195, 1997.
53. Nimura, Y., Yokoyama, S., Fujimori, M., Aoki, T., Adachi, W., Nasu, T., He, M., Ping, Y-M., and Iida, F. Genotyping of the CYP1A1 and GSTM1 genes in esophageal carcinoma patients with special reference to smoking. Cancer (Phila.), 80: 852-857, 1997.
54. Morita, S., Yano, M., Tsujinaka, T., Ogawa, A, Taniguchi, M., Kaneko, K., Shiozaki, H., Doki, Y., Inoue, M., and Monden, M. Association between genetic polymorphisms of glutathione S-transferase P1 and N-acetyltransferase 2 and susceptibility to squamous-cell carcinoma of the esophagus. Int. J. Cancer, 79: 517-520, 1998.
55. Arand, M., Muhlbauer, R., Hengstler, J., Jager, E., Fuchs, J., Winkler, L., and Oesch, F. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem., 236: 184-186, 1995.
56. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research. I. The Analysis of Case-Control Studies. IARC Scientific Publ. No. 32, pp. 5-338. Lyon, France: IARC, 1980.
57. Wu, X., Shi, H., Jiang, H., Kemp, B., Hong, W. K., Delclos, G. L., and Spitz, M. R. Association between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis (Lond.) 18: 967-973, 1997.
58. Le Marchand, L., Sivaraman, L., Pierce, L., Seifried, A., Lum, A., Wilkens, L. R., and Lau, A. F. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res., 58: 4858-4863, 1998.
59. London, S. J., Daly, A. K., Cooper, J., Carpenter, C. L., Navidi, W. C., Ding, L., and Idle, J. R. Lung cancer risk in relation to the CYP2EI RsaI genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics, 6: 151-158, 1996.
60. Anwar, W. A., Abdel-Rahman, S. Z., El-Zein, R. A., Mostafa, H. M., Au, W. W. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis (Lond.), 17: 1923-1929, 1996.
61. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., Karjalainen, A., and Vainio, H. The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis (Lond.), 14: 85-88, 1993.
62. Matthias, C., Bockmuhl, U., Jahnke, V., Jones, P. W., Hayes, J. D., Alldersea, J., Gilford, J., Bailey, L., Bath, J., Worrall, S. E., Hand, P., Fryer, A. A., and Strange, R. C. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics, 8: 91-100, 1998.
63. Hung, H-C., Chuang, J., Chien, Y-C., Chern, H-D., Chiang, C-P., Hildesheim, A., and Chen, C-J. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1: environmental factors and risk of oral cancer. Cancer Epidemiol, Biomark, Prev., 6: 901-905, 1997.
64. Hildesheim, A., Anderson, L. M., Chen, C-J., Cheng, Y-J., Brinton, L. A., Daly, A. K., Reed, C. D., Chen, I-H., Caporaso, N. E., Hsu, M-M., Chen, J-Y., Idle, J. R., Hoover, R. N., Yang, C-S., and Chhabra, S. K. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J. Natl. Cancer Inst., 89: 1207-1212, 1997.
65. Druckrey, H., Preussmann, R., Ivankovic, S., and Schmahl, D. Organotrope carcinogene Wirkung bei 65 verschiedenen N-nitroso-verbindungen an BD-Ratten. Z. Krebsforsch., 69: 103-201, 1967.
66. Umbenhauer, D., Wild, C. P., Montesano, R., Saffhill, R., Boyle, J. M., Huh, N., Kirstein, U., Thomale, J., Rajewsky, M. F., and Lu, S. H. Methyldeoxyguanosine in esophageal DNA among individuals at high risk of esophageal cancer. Int. J. Cancer, 36: 661-665, 1985.
67. Gao, Y. T., Mclaughlin, J. K., Blot, W. J., Ji, B. T., Benichou, J., Dai, Q., Fraumeni, J. F., Jr. Risk factor for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int. J. Cancer, 58: 192-196, 1994.
68. Hu, J., Nyren, O., Wolk, A., Bergstrom, R., Yuen, J., Adami, H. O., Guo, L., Li, H., Huang, G., and Xu, X. Risk factors for oesophageal cancer in northeast China. Int. J. Cancer, 57: 38-46, 1994.
69. Yu, Y., Taylor, P. R., Li, J. Y., Dawsey, S. M., Wang, G. Q., Guo, W. D., Wang, W., Liu, B. Q., Blot, W. J., Shen, Q., and Li, B. Retrospective cohort study of risk factors for esophageal cancer in Linxian, People's Republic of China, Cancer Causes Control, 4: 195-202, 1993.
70. Li, J. Y., Ershow, A. G., Chen, Z. J., Wacholder, S., Li, G. Y., Guo, W., Li, B., and Blot, W. J. A case-control study of cancer of the esophagus and gastric cardia in Linxian. Int. J. Cancer, 43: 755-761, 1989.
71. Saito, K., Yamazoe, Y., Kamataki, T., and Kato, R. Activation and detoxification of N-hydroxy-Trp-P-2 by glutathione transferases. Carcinogenesis (Lond.), 4: 1551-1557, 1983.
72. Guengerich, F. P., Peterson, L. A., Cmarik, J. L., Koga, N., and Inskeep, P. B. Activation of dihaloalkanes by glutathione conjugation and formation of DNA adducts. Environ. Health Perspect., 76: 15-18, 1987.
73. Sherratt, P. J., Pulford, D. J., Harrison, D. J., Green, T., and Hayes, J. D. Evidence that human class θ glutathione S-transferase T1-1 can catalyse the activation of dichloromethane, a liver and lung carcinogen in the mouse. Biochem. J., 326: 837-846, 1997.
74. World Cancer Research Fund, and American Institute for Cancer Research. Food, Nutrition, and Prevention of Cancer: A Global Perspective, pp. 118-129. Washington, DC: American Institute for Cancer Research, 1997.
75. Verhoeven, D. T. H., Verhagen, H., Golbohm, R. A., van den Brandt, P. A., and van Poppel, G. A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem. Biol. Interact., 103: 79-129, 1997.
76. Barcelo, S., Gardiner, J. M., Gescher, A., and Chipman, J. K. CYP2E1-mediated mechanism of anti-genotoxicity of the broccoli constituent sulforaphane. Carcinogenesis (Lond.), 17: 277-282, 1996.
77. Ishizaki, H., Brady, J. F., Ning, S. M., and Yang, C. S. Effect of phenethyl isothiocyanate on microsomal N-nitrosodimethylamine metabolism and other monooxygenase activities. Xenobiotica, 20: 255-264, 1990.
78. Leclercq, L., Desago, J-P., and Horsman, Y. Inhibition of chlorzoxazone metabolism, a clinic probe for CYP2E1, by a single ingestion of watercress. Clin. Pharmacol. Ther., 64: 144-149, 1998.
79. Maheo, K., Morel, F., Langouet, S., Kramer, H., Ferrec, E. L., Ketterer, B., and Guillouzo, A. Inhibition of cytochromes P-450 and induction of glutathione S-transferases by sulforaphane in primary human and rat hepatocytes. Cancer Res., 57: 3649-3652, 1997.
80. Zhang, Y., Kolm, R. H., Mannervik, B., and Talalay, P. Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. Biochem. Biophys. Res. Commun., 206: 748-755, 1995.
81. Kolm, R. H., Danielson, U. H., Zhang, Y., Talalay, P., and Mannervik, B. Isothiocyanates as substrates for human glutathione transferases: structure-activity studies. Biochem. J., 311: 453-459, 1995.
82. Lin, H. J., Probst-Hensch, N. M., Louie, A. D., Kau, I. H., Witte, K. J., Ingles, S. A., Frankl, H. D., Lee, E. R., and Haile, R. W. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol. Biomark. Prev., 7: 647-652, 1998.